405 related articles for article (PubMed ID: 35795081)
21. Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen.
Kimura S; Khalil IA; Elewa YHA; Harashima H
J Control Release; 2021 Feb; 330():753-764. PubMed ID: 33422500
[TBL] [Abstract][Full Text] [Related]
22. A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug.
Togashi R; Tanaka H; Nakamura S; Yokota H; Tange K; Nakai Y; Yoshioka H; Harashima H; Akita H
J Control Release; 2018 Jun; 279():262-270. PubMed ID: 29673647
[TBL] [Abstract][Full Text] [Related]
23. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
Kulkarni JA; Myhre JL; Chen S; Tam YYC; Danescu A; Richman JM; Cullis PR
Nanomedicine; 2017 May; 13(4):1377-1387. PubMed ID: 28038954
[TBL] [Abstract][Full Text] [Related]
24. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
25. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of phosphatidylserine improves efficiency of lipid based gene delivery systems.
Lotter C; Alter CL; Bolten JS; Detampel P; Palivan CG; Einfalt T; Huwyler J
Eur J Pharm Biopharm; 2022 Mar; 172():134-143. PubMed ID: 35181492
[TBL] [Abstract][Full Text] [Related]
27. High-Throughput
Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
[TBL] [Abstract][Full Text] [Related]
28. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
29. Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids.
Patel MN; Tiwari S; Wang Y; O'Neill S; Wu J; Omo-Lamai S; Espy C; Chase LS; Majumdar A; Hoffman E; Shah A; Sárközy A; Katzen J; Pardi N; Brenner JS
bioRxiv; 2024 Jun; ():. PubMed ID: 38915627
[TBL] [Abstract][Full Text] [Related]
30. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy.
Soroudi S; Jaafari MR; Arabi L
J Control Release; 2024 Jun; 372():113-140. PubMed ID: 38876358
[TBL] [Abstract][Full Text] [Related]
31. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
32. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
[TBL] [Abstract][Full Text] [Related]
33. In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA.
Medjmedj A; Ngalle-Loth A; Clemençon R; Hamacek J; Pichon C; Perche F
Nanomaterials (Basel); 2022 Jul; 12(14):. PubMed ID: 35889670
[TBL] [Abstract][Full Text] [Related]
34. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.
Kheirolomoom A; Kare AJ; Ingham ES; Paulmurugan R; Robinson ER; Baikoghli M; Inayathullah M; Seo JW; Wang J; Fite BZ; Wu B; Tumbale SK; Raie MN; Cheng RH; Nichols L; Borowsky AD; Ferrara KW
Biomaterials; 2022 Feb; 281():121339. PubMed ID: 35078042
[TBL] [Abstract][Full Text] [Related]
35. Polyphosphate coated nanoparticles: Enzyme-activated charge-reversal gene delivery systems.
Akkuş-Dağdeviren ZB; Arısoy S; Friedl JD; Fürst A; Saleh A; Bernkop-Schnürch A
Int J Pharm; 2023 Nov; 646():123474. PubMed ID: 37793466
[TBL] [Abstract][Full Text] [Related]
36. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
[TBL] [Abstract][Full Text] [Related]
37. Ionizable Lipids with Triazole Moiety from Click Reaction for LNP-Based mRNA Delivery.
Wang Y; Si X; Feng Y; Feng D; Xu X; Zhang Y
Molecules; 2023 May; 28(10):. PubMed ID: 37241787
[TBL] [Abstract][Full Text] [Related]
38. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
39. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
[TBL] [Abstract][Full Text] [Related]
40. Multi-step screening of DNA/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression.
Zhu Y; Shen R; Vuong I; Reynolds RA; Shears MJ; Yao ZC; Hu Y; Cho WJ; Kong J; Reddy SK; Murphy SC; Mao HQ
Nat Commun; 2022 Jul; 13(1):4282. PubMed ID: 35879315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
